Abrilumab (AMG 181) in Adults With Moderate to Severe Ulcerative Colitis

Clinical trial NCT01694485 · COMPLETED

Trial details

NCT number: NCT01694485
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Ulcerative Colitis

Start date: 2012-11-16
Primary completion: 2015-07-13
Enrollment: 359

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.